B. van Schaeybroeck

Do we need to lower the cut point of the 2010 ACR/EULAR classification criteria for diagnosing rheumatoid arthritis?

D. van Zeben, A. Gerards, J. Luime, 2016, Rheumatology.

Randomised comparison of initial triple DMARD therapy with methotrexate monotherapy in combination with low-dose glucocorticoid bridging therapy; 1-year data of the tREACH trial

D. van Zeben, A. Gerards, M. V. van Krugten, 2014, Annals of the rheumatic diseases.

Methotrexate polyglutamates in erythrocytes are associated with lower disease activity in patients with rheumatoid arthritis

A. Gerards, N. Wulffraat, S. Pluijm, 2013, Annals of the rheumatic diseases.

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

M. A. van de Laar, R. Landewé, P. V. van Riel, 2019, BMC Rheumatology.

Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment

M. A. van de Laar, R. Landewé, P. V. van Riel, 2019, BMC Rheumatology.